Earnings Feed
Start Free
Home/Filings/4/0001127602-22-002958
4//SEC Filing

Lotvin Alan 4

Accession 0001127602-22-002958

CIK 0000064803other
View on SEC.govCompany Profile

Filed

Feb 1, 7:00 PM ET

Accepted

Feb 2, 4:20 PM ET

Size

20.1 KB

Accession

0001127602-22-002958

Insider Transaction Report

Form 4
Period: 2022-02-01
CVS HEALTH CorpCVS
Lotvin Alan
EVP, Transformation
Transactions
  • Exercise/Conversion

    Stock Option

    2022-02-01−21,386→ 0 total
    Exercise: $102.26From: 2016-04-01Exp: 2022-04-01→ Common Stock (21,386 underlying)
  • Exercise/Conversion

    Common Stock

    2022-02-01$102.26/sh+21,386$2,186,932→ 82,727.369 total
  • Sale

    Common Stock

    2022-02-01$106.50/sh−21,386$2,277,566→ 61,341.369 total
Holdings

  • Stock Option

    Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (27,395 underlying)
    27,395

  • Common Stock (restricted)

    5,827

  • Stock Unit

    29,851.161

  • Stock Option

    Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (140,797 underlying)
    140,797

  • Common Stock

    (indirect: By Trust)
    492

  • Stock Option

    Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (22,541 underlying)
    22,541

  • Phantom Stock Credits

    Exercise: $1.00→ Common Stock (556.764 underlying)
    556.764

  • Stock Option

    Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (32,911 underlying)
    32,911

  • Stock Option

    Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (70,702 underlying)
    70,702

  • Stock Option

    Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (120,940 underlying)
    120,940
Footnotes (11)
  • [F1]All sales were effected pursuant to a Rule 10b5-1 plan.
  • [F10]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F11]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
  • [F2]Option became exercisable in four equal annual installments, commencing 4/1/2016.
  • [F3]Option became exercisable in four equal annual installments, commencing 4/1/2017.
  • [F4]Option became exercisable in four equal annual installments, commencing 4/3/2018.
  • [F5]Option became exercisable in four equal annual installments, commencing 4/1/2019.
  • [F6]Option became exercisable in four equal annual installments, commencing 4/1/2020.
  • [F7]The number of shares subject to the option were calculated using a 30-day average price.
  • [F8]Option became exercisable in four equal annual installments, commencing 4/1/2021.
  • [F9]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.

Documents

1 file

Issuer

CVS HEALTH Corp

CIK 0000064803

→
Entity typeother

Related Parties

1
  • filerCIK 0001472795

Filing Metadata

Form type
4
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 4:20 PM ET
Size
20.1 KB
View on SEC.gov